Home » Topics » BioWorld Science

BioWorld Science
RSS

OG-716, a lantibiotic that is active against Clostridium difficile infections

July 12, 2018

Argenx presents phase II data for ARGX-113 in myasthenia gravis

July 12, 2018

Advaxis withdraws conditional MAA for axalimogene filolisbac, advances ADXS-HOT program

July 12, 2018

Recursion set to begin phase I study of AI/ML-based drug candidate, REC-994

July 12, 2018

First patient dosed in phase II study of CV-301 plus nivolumab in metastatic colorectal cancer

July 12, 2018

Tegsedi approved in the E.U. for the treatment of hATTR

July 12, 2018

Ovid Therapeutics initiates phase II ROCKET trial of OV-101 in fragile X syndrome

July 12, 2018

BioSight receives clearance to initiate phase IIb study of BST-236 in AML

July 12, 2018

[225Ac]DOTA-PEG7-5B1 as pretargeted radioimmunotherapy for pancreatic ductal adenocarcinoma

July 12, 2018

Investigating isoflavonoids for the potential treatment of obesity and diabetes

July 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...